NCT07157722View on ClinicalTrials.gov

Evaluating the Effect of N-Acetyl Cysteine and Alpha Lipoic Acid in Patients With Beta Thalassemia

PHASE3Not yet recruitingINTERVENTIONAL
Enrollment

66

Participants

Timeline

Start Date

August 30, 2025

Primary Completion Date

December 30, 2025

Study Completion Date

January 30, 2026

Conditions
Beta Thalassemia
Interventions
DRUG

Iron chelating intervention

JADENU is indicated for the treatment of chronic iron overload due to blood transfusions.

DRUG

N Acetyl cysteine 600mg

N-acetyl cysteine (NAC) 600 mg will be administered orally once daily for 12 weeks.

DRUG

Alpha Lipoic Acid 600 MG Oral Tablets

Alpha lipoic acid (ALA) 600 mg will be administered orally once daily for 12 weeks.

Trial Locations (1)

31511

Faculty of Pharmacy - Tanta University, Tanta

All Listed Sponsors
lead

Tanta University

OTHER